Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKliniken Essen-Mitte
About this trial
This study is a monocentric uncontrolled observational study to evaluate a 12-14 day inpatient stay in an internal medicine clinic for integrative and complementary medicine for patients with episodic migraine and/or episodic tension headache. The aim is to investigate the extent to which a 14-day inpatient stay can influence a reduction in headache days and/or pain intensity, medication use, quality of life, anxiety, depression, perceived stress, general well-being, and a reduction in sick days/work absenteeism, and prevent the chronification of migraine and may counteract the chronification of migraine or tension-type headache. In addition, patients' previous experiences with complementary naturopathic therapies, expectations and perceived benefits in everyday life will be analysed.
Eligibility criteria
Qualifiers
Episodic migraine (<15 headache days/month in the last 3 months)
Episodic tension headache (<15 headache days/month in the last 3 months)
Mixed forms or parallel occurrence of both types of headache is permitted
Diagnosis confirmed in advance by a neurologist
Disqualifiers
Age younger than 18 years
Chronic migraine (15 migraine days in the last 3 months) or chronic tension type headache
Medication-induced headache/painkiller abuse (> 10 triptans/combination analgesics/ergotamines/opiates or >15 classical analgesics per month)
Acute severe mental illness (e.g. severe depression with suicidal tendencies)
Trial design
Treatments tested in this trial
- integrative and complementary medicine
Treatment groups
130 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov